# Prevention of Post-operative Pneumonia (POPP)

> **NCT01446874** · PHASE2,PHASE3 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 150 (actual)

## Conditions studied

- Post-operative Pneumonia
- Lung Cancer
- Esophageal Cancer

## Interventions

- **DRUG:** 0.12% chlorhexidine solution

## Key facts

- **NCT ID:** NCT01446874
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-09-22
- **Primary completion:** 2015-12-13
- **Final completion:** 2015-12-13
- **Target enrollment:** 150 (ACTUAL)
- **Why stopped:** Slow patient accrual and plans to perform multi-center study
- **Last updated:** 2018-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01446874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01446874, "Prevention of Post-operative Pneumonia (POPP)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01446874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*